Literature DB >> 10399751

Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.

J L De Bleecker1, V I Meire, W Declercq, E H Van Aken.   

Abstract

Adhesion molecule upregulation occurs in inflammatory myopathies, and is one of the myriad functions of tumor necrosis factor-alpha (TNF-alpha). TNF-alpha acts via two different receptors of 55 (TNF-R55) and 75 kD (TNF-R75). We immunolocalized TNF-alpha and its receptors in polymyositis, inclusion body myositis and dermatomyositis. In each myopathy, TNF-alpha was detected in macrophages, in myonuclei in regenerating muscle fibers, and freely dispersed in endomysial or perimysial connective tissue. Many endothelial cells in dermatomyositis expressed TNF-alpha. TNF-R55 was strongly expressed on myonuclei of regenerating muscle fibers. TNF-R75 was increased on endothelial cells in the midst of inflammatory infiltrates in each myopathy, and on perifascicular and perimysial endothelia, remote from inflammatory foci in dermatomyositis. Possible TNF-alpha-mediated effects include: increased transendothelial cell trafficking, activation of T/B cells and macrophages, induction of MHC-I gene products, and focal muscle fiber atrophy. In dermatomyositis, the upregulated TNF-R75, via its consensus elements for transcription factors, may be involved in endothelial cell degeneration. Strong TNF-R55 expression on regenerating myonuclei is consistent with a role of TNF-alpha and TNF-R55 in muscle regeneration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399751     DOI: 10.1016/s0960-8966(98)00126-6

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  39 in total

1.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.

Authors:  Stephan Seeliger; Thomas Vogl; Ingo Hubert Engels; J Michael Schröder; Clemens Sorg; Cord Sunderkötter; Johannes Roth
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

2.  Tumor necrosis factor inhibitor-associated dermatomyositis.

Authors:  Rachel Klein; Misha Rosenbach; Ellen J Kim; Brian Kim; Victoria P Werth; Jonathan Dunham
Journal:  Arch Dermatol       Date:  2010-07

3.  Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies.

Authors:  K M Rostasy; J Schmidt; E Bahn; T Pfander; M Piepkorn; E Wilichowski; J Schulz-Schaeffer
Journal:  Acta Myol       Date:  2008-10

4.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

5.  Inflammatory myopathies.

Authors:  B Jane Distad; Anthony A Amato; Michael D Weiss
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

6.  Does computed tomography-based muscle density predict muscle function and health-related quality of life in patients with idiopathic inflammatory myopathies?

Authors:  Laura C Cleary; Leslie J Crofford; Douglas Long; Richard Charnigo; Jody Clasey; Francesca Beaman; Kirk A Jenkins; Natasha Fraser; Archana Srinivas; Nicole Dhaon; Beatriz Y Hanaoka
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

7.  A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.

Authors:  Adam Schiffenbauer; Megha Garg; Christine Castro; Angelina Pokrovnichka; Galen Joe; Joseph Shrader; Imelda Victoria Cabalar; Sara Faghihi-Kashani; Michael O Harris-Love; Paul H Plotz; Frederick W Miller; Mark Gourley
Journal:  Semin Arthritis Rheum       Date:  2017-10-16       Impact factor: 5.532

8.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

9.  Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle.

Authors:  Shuen-Ei Chen; Eric Gerken; Yingmin Zhang; Mei Zhan; Raja K Mohan; Andrew S Li; Michael B Reid; Yi-Ping Li
Journal:  Am J Physiol Cell Physiol       Date:  2005-08-03       Impact factor: 4.249

Review 10.  Disease-Induced Skeletal Muscle Atrophy and Fatigue.

Authors:  Scott K Powers; Gordon S Lynch; Kate T Murphy; Michael B Reid; Inge Zijdewind
Journal:  Med Sci Sports Exerc       Date:  2016-11       Impact factor: 5.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.